We are live on ! Find out more
ICCC icon

ImmuCell
ICCC

19 hedge funds and large institutions have $6.69M invested in ImmuCell in 2016 Q3 according to their latest regulatory filings, with funds opening new positions, 8 increasing their positions, 5 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

60% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 5

6% more capital invested

Capital invested by funds: $6.32M → $6.69M (+$368K)

10% less funds holding

Funds holding: 21 → 19 (-2)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

Holders
19
Holders Change
-2
Holders Change %
-9.52%
% of All Funds
0.51%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
8
Reduced
5
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
HA
Heartland Advisors
Wisconsin
+$146K
2
Renaissance Technologies
Renaissance Technologies
New York
+$66.2K
3
SRC
Shufro Rose & Co
New York
+$14.6K
4
Deutsche Bank
Deutsche Bank
Germany
+$13.1K
5
TRCT
Tower Research Capital (TRC)
New York
+$1.61K

Top Sellers

Rank Fund Capital Flow
1
NC
Northpointe Capital
Michigan
-$540K
2
Morgan Stanley
Morgan Stanley
New York
-$53.9K
3
Vanguard Group
Vanguard Group
Pennsylvania
-$8.73K
4
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$3.64K
5
UMA
USA Mutuals Advisors
Texas
-$3K
Name Holding Trade Value Shares
Change 		Change in
Stake
HA
1
Heartland Advisors
Wisconsin
$1.74M +$146K +20,028 +10%
NC
2
Northpointe Capital
Michigan
$1.39M -$540K -74,242 -29%
HP
3
HealthInvest Partners
Sweden
$1.3M – – –
PCM
4
Perritt Capital Management
Illinois
$639K +$364 +50 +0.1%
Renaissance Technologies
5
Renaissance Technologies
New York
$567K +$66.2K +9,100 +14%
SRC
6
Shufro Rose & Co
New York
$342K +$14.6K +2,000 +5%
EFS
7
Essex Financial Services
Connecticut
$184K – – –
Vanguard Group
8
Vanguard Group
Pennsylvania
$167K -$8.73K -1,200 -5%
Morgan Stanley
9
Morgan Stanley
New York
$136K -$53.9K -7,410 -30%
MA
10
Minerva Advisors
Pennsylvania
$112K – – –
UBS Group
11
UBS Group
Switzerland
$33K -$1.1K -151 -3%
Deutsche Bank
12
Deutsche Bank
Germany
$27K +$13.1K +1,800 +101%
Bank of America
13
Bank of America
North Carolina
$18K +$1.55K +213 +10%
Acadian Asset Management
14
Acadian Asset Management
Massachusetts
$15K – – –
Wells Fargo
15
Wells Fargo
California
$8K – – –
BFA
16
BlackRock Fund Advisors
California
$6K +$415 +57 +8%
Royal Bank of Canada
17
Royal Bank of Canada
Ontario, Canada
$4K -$3.64K -500 -50%
TRCT
18
Tower Research Capital (TRC)
New York
$4K +$1.61K +221 +67%
UMA
19
USA Mutuals Advisors
Texas
– -$3K -471 Closed
Creative Planning
20
Creative Planning
Kansas
– -$2K -310 Closed

ICCC Hedge Fund Activity: Q3 2016 in Review

19 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in ImmuCell (ICCC) for Q3 2016, worth a combined $6.69M — up 5.8% from $6.32M a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of ICCC and 0 opened new positions — a net loss of 2 holders — while 5 trimmed existing stakes and 8 added.

The largest buyer was Heartland Advisors, adding an estimated $146K. The largest seller was Northpointe Capital, cutting an estimated $540K.

  • 19 institutional investors held ImmuCell (ICCC) as of Q3 2016, down from 21 in Q2 2016.
  • Funds reported $6.69M of ImmuCell stock for Q3 2016, up 5.8% quarter-over-quarter.
  • 0 funds opened new ImmuCell positions in Q3 2016 and 2 closed out, a net change of -2 holders.
  • The largest ImmuCell buyer in Q3 2016 was Heartland Advisors, an estimated $146K added.
  • The largest ImmuCell seller in Q3 2016 was Northpointe Capital, an estimated $540K sold.

Based on aggregated 13F filings for Q3 2016.